{"url":"https://lda.gov/api/v1/filings/25cb76c6-3f73-4a82-94f4-4ee38c0203bc/","filing_uuid":"25cb76c6-3f73-4a82-94f4-4ee38c0203bc","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/25cb76c6-3f73-4a82-94f4-4ee38c0203bc/print/","filing_document_content_type":"text/html","income":"250000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"David Friedman","dt_posted":"2026-04-20T13:32:13-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2332 Galiano St","registrant_address_2":"2nd Floor","registrant_different_address":false,"registrant_city":"Coral Gables","registrant_state":"FL","registrant_zip":"33134","registrant":{"id":401110165,"url":"https://lda.gov/api/v1/registrants/401110165/","house_registrant_id":77353,"name":"MR. DAVID FRIEDMAN","description":null,"address_1":"2332 Galiano St","address_2":"2nd Floor","address_3":null,"address_4":null,"city":"Coral Gables","state":"FL","state_display":"Florida","zip":"33134","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID FRIEDMAN","contact_telephone":"+1 202-737-8808","dt_updated":"2026-07-17T14:31:22.573504-04:00"},"client":{"id":70210,"url":"https://lda.gov/api/v1/clients/70210/","client_id":70210,"name":"TEVA PHARMACEUTICALS USA, INC.","general_description":"Pharmaceutical manufacturer.","client_government_entity":null,"client_self_select":false,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-11-01"},"lobbying_activities":[{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"Issues related to strengthening the domestic supply and manufacture of essential medicines.","foreign_entity_issues":"Teva Pharmaceutical Industries Ltd., identified on Registration (LD-1) as the parent company, would benefit from similar opportunities as identified in this report related to the domestic manufacturing of essential medicines.","lobbyists":[{"lobbyist":{"id":152228,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"FRIEDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues related to strengthening the domestic supply and manufacture of essential medicines.","foreign_entity_issues":"Teva Pharmaceutical Industries Ltd., identified on Registration (LD-1) as the parent company, would benefit from similar opportunities as identified in this report related to the domestic manufacturing of essential medicines.","lobbyists":[{"lobbyist":{"id":152228,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"FRIEDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}